Tender for the supply of "Spinraza" DDCHDPDS.SPYY 171/2024 (OAY)
About This Opportunity
TranslatedThis tender, originating from Cyprus and published on the TED (Tenders Electronic Daily) platform, seeks offers for the procurement of "Spinraza". The contracting authority is the Organisation of Healthcare Services (OAY). This procurement falls under the category of pharmaceutical supplies and specialized medical treatments, indicating a need for a high-value, potentially life-altering medication.
The tender is for the supply of Spinraza, a drug used in the treatment of Spinal Muscular Atrophy (SMA). Interested suppliers are expected to be reputable pharmaceutical manufacturers or authorized distributors with proven experience in supplying such specialized and regulated medical products. Typical requirements for this type of tender would include demonstrating the ability to meet stringent quality standards, ensuring a reliable and secure supply chain, and adhering to all relevant national and international pharmaceutical regulations.
Bidders will likely need to provide comprehensive documentation regarding product registration, manufacturing capabilities, quality control processes, and pharmacovigilance systems. Furthermore, evidence of financial stability and the capacity to manage large-scale distribution logistics within Cyprus will be crucial. The tender process will involve a detailed evaluation of technical proposals, pricing, and the overall ability of the supplier to meet the specific clinical and logistical demands associated with the provision of Spinraza. This procurement represents a significant investment in public health, aiming to ensure patient access to essential treatments.
This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in CY, Europe, this opportunity is open to firms and consortiums.
Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: GreekThis tender, originating from Cyprus and published on the TED (Tenders Electronic Daily) platform, seeks offers for the procurement of "Spinraza". The contracting authority is the Organisation of Healthcare Services (OAY).
This procurement falls under the category of pharmaceutical supplies and specialized medical treatments, indicating a need for a high-value, potentially life-altering medication.
The tender is for the supply of Spinraza, a drug used in the treatment of Spinal Muscular Atrophy (SMA).
Interested suppliers are expected to be reputable pharmaceutical manufacturers or authorized distributors with proven experience in supplying such specialized and regulated medical products. Typical requirements for this type of tender would include demonstrating the ability to meet stringent quality standards, ensuring a reliable and secure supply chain, and adhering to all relevant national and international pharmaceutical regulations.
Bidders will likely need to provide comprehensive documentation regarding product registration, manufacturing capabilities, quality control processes, and pharmacovigilance systems. Furthermore, evidence of financial stability and the capacity to manage large-scale distribution logistics within Cyprus will be crucial. The tender process will involve a detailed evaluation of technical proposals, pricing, and the overall ability of the supplier to meet the specific clinical and logistical demands associated with the provision of Spinraza.
This procurement represents a significant investment in public health, aiming to ensure patient access to essential treatments.
Data provenance
This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on March 17, 2025. Last refreshed 13 days ago. Original language: Greek. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Υπουργείο Υγείας
Υπουργείο Υγείας has issued 159 procurement notices on BidsFactory, including 17 currently open and 102 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Construction & Civil Works. All notices are published for CY. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: July 2, 2026.
Frequently asked questions about this tender
Is this tender still open?
No — the contract has already been awarded to GENESIS PHARMA (CYPRUS) LTD. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Υπουργείο Υγείας in CY. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
GENESIS PHARMA (CYPRUS) LTD was awarded the contract for €1,660,800. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in CY. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.